Jonathan has spent the last 15+ years of his career building high performing teams and companies in the healthcare and life sciences industries, with a passion for driving commercial innovation in the intersection of data proliferation and technological advancement. At IPM.ai, his team’s current focus is around artificial intelligence and machine learning with a focus in specialty markets, rare disease, and Oncology.
As a thought leader in the space, Jonathan is a regular presenter at leading industry conferences—most recently at Healthcare Information and Management Systems Society (HIMSS), as well as at the Pharmaceutical Management Science Association (PMSA) and National Organization for Rare Disease (NORD)—on the topic of leveraging de-identified patient level data and machine learning to identity undiagnosed rare disease patients, and improving healthcare outcomes.